Key result
Activin-A remains elevated in PPCM through six months but is not linked to LV recovery.
Why the study?
Elevated circulating Activin-A levels have been associated with heart failure severity in acute PPCM patients, but their behavior during left ventricular recovery is unclear.
Observational (n=178)
Activin-A serum levels are persistently elevated in patients with peripartum cardiomyopathy but do not correlate with left ventricular recovery or disease severity markers.
Answers are grounded in this paper and cite their sources.
Elevated Activin-A is not linked to LV recovery in PPCM; hypothesis-generating and should not yet change practice.
BACKGROUND AND AIMS: Peripartum cardiomyopathy (PPCM) is an idiopathic form of heart failure occurring in the peripartum phase. Elevated circulating levels of the senescence-associated-secretory-phenotype (SASP) factor Activin-A have been associated with heart failure severity in acute PPCM patients at baseline diagnosis. Here, we investigated Activin-A serum levels in the German PPCM registry in acute PPCM and during left ventricular (LV) recovery. METHODS AND RESULTS: Clinical data including LV ejection fraction (LVEF) and Activin-A serum levels were assessed at initial diagnosis (baseline [BL]) and during follow-up (FU) at 3 months (M) and 6M in PPCM patients from the German PPCM Registry (n = 151, mean age 33 ± 5 years) compared to postpartum healthy controls (n = 27, mean age 32 ± 5 years). Activin-A serum levels at BL were elevated (404 pg/ml; interquartile range [IQR]: 197-815, n = 151) compared to healthy postpartum controls (240 pg/ml, IQR:148-446, n = 27; P < .01) and remained persistently elevated above postpartum healthy controls at 3 M (418 pg/ml, IQR: 169-806, n = 100) and 6M-FU (520 pg/ml, IQR: 214-1131, n = 104). Activin-A levels at BL did not correlate with LVEF (Spearman r = 0.10, P = .2416, n = 139), NT-proBNP (r = 0.096, P = .2766, n = 131), CRP (r = -0.0008, P = .9933; n = 110) or PPCM biomarker plasminogen-activator-inhibitor-1 (PAI-1) (r = 0.095, P = .3273, n = 109). The majority of PPCM patients showed LV recovery 6M after initial diagnosis, indicated by improved LVEF (PPCM BL: 25%, IQR: 20-33, n = 152; 6M-FU: 52% IQR: 45-56, n = 128, P < .0001). Activin-A levels did not differ between full or incomplete LV recovery, or between patients with hypertensive pregnancy disorders. CONCLUSIONS: In PPCM patients from the German PPCM registry Activin-A serum levels were elevated at diagnosis, remained persistently high after 3M- and 6M-FU but were not associated with LV recovery.
No takes yet. Share an insight, caveat, or question.
Gausepohl et al. (2026) conducted an observational in Peripartum cardiomyopathy (n=178). Acute peripartum cardiomyopathy vs. Postpartum healthy controls was evaluated on Activin-A serum levels at baseline (pg/ml) (p=<.01). Acute peripartum cardiomyopathy was associated with elevated baseline Activin-A serum levels compared to healthy controls, which remained high but did not predict LV recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: